MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

12 Oct 2023 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release received from Ichnos Sciences Inc. (wholly owned subsidiary of the Company) regarding Ichnos Sciences Enters Licensing Agreement for OX40 Antagonist Monoclonal Antibody Portfolio with Astria Therapeutics.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..